ArticleWorld journal of nephrology2025
Risk factors for developing acute kidney injury after heart transplant: A systematic review and meta-analysis.
Article in World journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Risk factors and prognostic impact of continuous renal replacement therapy after heart transplantation: a single-center retrospective study.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute kidney injury (AKI) is a common and serious complication following heart transplantation, significantly impacting patient outcomes and survival rates. AKI after transplantation can lead to prolonged hospital stays, increased morbidity, and even mortality.
aimTo identify and quantify significant risk factors associated with AKI following heart transplantation through a systematic review and meta-analysis. This study aims to distinguish predictive variables that may inform perioperative risk stratification and clinical decision-making.
methodsElectronic searches on MEDLINE, Google Scholar, ScienceDirect, ClinicalTrials.gov, and Cochrane databases were conducted from inception up till September 1. Included studies were randomized controlled trials, clinical trials, retrospective cohort, and observational studies. Exclusion criteria encompassed studies with pediatric populations, non-English publications, case reports, and studies lacking sufficient data on AKI outcomes. Statistical analysis was performed using RevMan 5.4, reporting dichotomous outcomes as odds ratios (OR) and continuous outcomes as mean differences (MD) with 95% confidence intervals (CI). Quality assessment of the included studies was performed using the New Castle Ottawa Scale.
resultsOut of 1345 articles, 13 studies with 3330 patients were included. Significant risk factors included age [overall MD = 2.27 years (95%CI: 0.13 to 4.41)], body mass index (BMI) [MD = 1.42 (95%CI: 0.60 to 2.24)], diabetes [overall OR = 1.47 (95%CI: 1.16 to 1.85)], chronic kidney disease (CKD) [OR = 2.67 (95%CI: 1.73 to 4.14)], chronic obstructive pulmonary disorder (COPD) [OR = 0.49 (95%CI: 0.27 to 0.89)], previous thoracic surgery [(OR) = 1.27, 95%CI: (1.05 to 1.54)], cardio-pulmonary bypass time [(MD) = 17.10, 95%CI: (6.12 to 28.08)], mechanical ventilation duration [(MD) = 30.87 hours, 95%CI: (10.69 to 51.05)] and extracorporeal membrane oxygenation [(OR) = 2.31, 95%CI: (1.25 to 4.26)]. Factors not associated with AKI after heart transplantation included Recipients' male sex (
conclusionAge, BMI, diabetes, CKD, COPD, previous thoracic surgery, prolonged CPB time, extended mechanical ventilation, and ECMO use are significant predictors of AKI following heart transplantation, necessitating vigilant monitoring and individualized risk assessment. Conversely, factors such as LVAD implantation and inotrope use showed no significant association, highlighting the need for further investigation into their roles. Future prospective studies are essential to validate these findings, elucidate underlying mechanisms, and develop targeted interventions to mitigate AKI risk and improve patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.